Cargando…
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
In recent years there has been growing interest in the potential benefits of CBD-rich cannabis treatment for children with ASD. Several open label studies and one double-blind placebo-controlled study have reported that CBD-rich cannabis is safe and potentially effective in reducing disruptive behav...
Autores principales: | Hacohen, Micha, Stolar, Orit E., Berkovitch, Matitiahu, Elkana, Odelia, Kohn, Elkana, Hazan, Ariela, Heyman, Eli, Sobol, Yael, Waissengreen, Danel, Gal, Eynat, Dinstein, Ilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461457/ https://www.ncbi.nlm.nih.gov/pubmed/36085294 http://dx.doi.org/10.1038/s41398-022-02104-8 |
Ejemplares similares
-
The Relations between Repetitive Behaviors and Family Accommodation among Children with Autism: A Mixed-Methods Study
por: Shiloh, Gal, et al.
Publicado: (2023) -
Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety
por: Stolar, Orit, et al.
Publicado: (2022) -
Lacosamide effects on placental carriers of essential compounds in comparison with valproate: Studies in perfused human placentas
por: Berman, Erez, et al.
Publicado: (2022) -
Therapeutic drug monitoring of lacosamide among children: is it helpful?
por: Kohn, Elkana, et al.
Publicado: (2023) -
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
por: Treves, Nir, et al.
Publicado: (2021)